Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 150,000 shares at $37.12 ($5.6M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $5.6M AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.12 | 24,400 | $906K | 16.3% |
| 2 | $37.12 | 24,401 | $906K | 16.3% |
| 3 | $37.12 | 24,400 | $906K | 16.3% |
| 4 | $37.12 | 24,401 | $906K | 16.3% |
| 5 | $37.13 | 24,700 | $917K | 16.5% |
| 6 | $37.13 | 24,700 |
| $917K |
| 16.5% |
| 7 | $37.75 | 600 | $23K | 0.4% |
| 8 | $37.75 | 600 | $23K | 0.4% |
| 9 | $37.78 | 599 | $23K | 0.4% |
| 10 | $37.78 | 599 | $23K | 0.4% |
| 11 | $37.86 | 300 | $11K | 0.2% |
| 12 | $37.86 | 300 | $11K | 0.2% |
| Total | $37.14 avg | 150,000 | $5.6M | 100% |
| Filing → |
| AIMT | SELL | 2017-09-07 | $405K | — | Filing → |
| AIMT | SELL | 2017-07-31 | $11K | — | Filing → |
| AIMT | SELL | 2017-07-25 | $134K | — | Filing → |